Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;60(9):565-570.
doi: 10.1111/jsap.13005. Epub 2019 May 1.

The effect of atorvastatin on haemostatic parameters in apparently healthy dogs

A Bonaparte  1 , C Tansey  2 , M Wiebe  2 , H E Espinoza  2 , J E Patlogar  2 , L A Murphy  3 , R K Nakamura  4
Affiliations

The effect of atorvastatin on haemostatic parameters in apparently healthy dogs

A Bonaparte et al. J Small Anim Pract. 2019 Sep.

Abstract

Objective: To determine the effect of atorvastatin on haemostatic parameters as measured by prothrombin time, activated partial thromboplastin time and thromboelastography in apparently healthy dogs administered 2 mg/kg orally once daily for 1 week.

Materials and methods: Prospective study of 20 apparently healthy client-owned dogs at a small animal specialty hospital. Dogs had a baseline complete blood count, serum chemistry profile, fibrinogen, platelet count, prothrombin time, activated partial thromboplastin time and thromboelastography performed. Each dog was then administered approximately 2 mg/kg of atorvastatin orally once daily for 1 week, and the laboratory tests were repeated. Adverse effects attributed to atorvastatin were recorded.

Results: All 20 enrolled dogs completed the study. Dogs received a median dose of 2.06 mg/kg (range 1.94 to 2.44 mg/kg) atorvastatin once daily, which was associated with a significant increase in pulse rate, mean corpuscular haemoglobin concentration, albumin and a significant decrease in mean corpuscular volume, cholesterol and lipase values compared with baseline. On thromboelastography, there was a significant increase in maximum amplitude, G, coagulation index, amplitude at 30 minutes, amplitude at 60 minutes and significant decrease in percentage of clot lysed at 30 minutes and percentage of clot lysed at 60 minutes values compared with baseline. Six dogs had a noticeable increase in appetite.

Clinical significance: The results of this study suggest that atorvastatin may produce a procoagulant effect in dogs, although the clinical significance is unclear. Polyphagia was the most commonly reported adverse effect.

PubMed Disclaimer

References

    1. Bakker-Arkema R.G., Davidson M.H., Goldstein R.J., Davignon J., Isaccsohn J.L, Weiss S.R., Keilson L.,M., Brown W.V., Miller V.T., Shurzinske L.J., & Black D.M. (1996). Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA 275, 128-133.
    1. Baldassarre, D., Porta, B., Camera, M., et al. (2009) Markers of inflammation, thrombosis, and endothelial activation correlate with carotid IMT regression stable coronary disease after atorvastatin treatment. Nutrition, Metabolism and Cardiovascular Diseases 19, 481-490
    1. Bartok, A., Steiner, S., Seidinger, D., et al. (2005) Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor. Thrombosis Research 115, 469-474
    1. Bruni, F., Pasqui, A. L., Pastorelli, M., et al. (2004) Effect of atorvastatin on different fibrinolysis mechanisms in hypercholesterolemic subjects. International Journal of Cardiology 95, 269-274
    1. Cunningham, S. M., Rush, J. E. & Freeman, L. M. (2013) Short-term effects of atorvastatin in normal dogs and dogs with congestive heart failure due to myxomatous mitral valve disease. Journal of Veterinary Internal Medicine 27, 985-989

LinkOut - more resources